S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
Profit From the Commercial Solar Boom? (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
What do Mastercard Earnings Indicate About Consumer Spending?
A gold storm is coming… (Ad)
How to Find Penny Stocks to Invest and Trade
ONSemi Is Marching Higher On Great Results
A gold storm is coming… (Ad)
What Tyson Foods Q1 Means For Staples Stocks
Can Cummins Power To A New High? 
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
Profit From the Commercial Solar Boom? (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
What do Mastercard Earnings Indicate About Consumer Spending?
A gold storm is coming… (Ad)
How to Find Penny Stocks to Invest and Trade
ONSemi Is Marching Higher On Great Results
A gold storm is coming… (Ad)
What Tyson Foods Q1 Means For Staples Stocks
Can Cummins Power To A New High? 
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
Profit From the Commercial Solar Boom? (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
What do Mastercard Earnings Indicate About Consumer Spending?
A gold storm is coming… (Ad)
How to Find Penny Stocks to Invest and Trade
ONSemi Is Marching Higher On Great Results
A gold storm is coming… (Ad)
What Tyson Foods Q1 Means For Staples Stocks
Can Cummins Power To A New High? 
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
Profit From the Commercial Solar Boom? (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
What do Mastercard Earnings Indicate About Consumer Spending?
A gold storm is coming… (Ad)
How to Find Penny Stocks to Invest and Trade
ONSemi Is Marching Higher On Great Results
A gold storm is coming… (Ad)
What Tyson Foods Q1 Means For Staples Stocks
Can Cummins Power To A New High? 
NASDAQ:GNCA

Genocea Biosciences - GNCA Price Target & Analyst Ratings

$0.0002
0.00 (0.00%)
(As of 02/3/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.0001
$0.0016
50-Day Range
$0.0002
$0.0150
52-Week Range
$0.0001
$0.0001
Volume
10,663 shs
Average Volume
83,499 shs
Market Capitalization
$11,746.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.00

Genocea Biosciences Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 2 Analyst Ratings

Consensus Analyst Price Target

$3.00
1,499,900.00% Upside
High Prediction$3.00
Average Prediction$3.00
Low Prediction$3.00
TypeCurrent
2/7/22 to 2/7/23
1 Month Ago
1/8/22 to 1/8/23
3 Months Ago
11/9/21 to 11/9/22
1 Year Ago
2/7/21 to 2/7/22
Consensus Rating
Hold
Hold
Hold
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
3 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$3.00$3.00$3.00$6.67
Predicted Upside1,499,900.00% Upside650.00% Upside650.00% Upside125.48% Upside
Get Genocea Biosciences Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for GNCA and its competitors with MarketBeat's FREE daily newsletter.

GNCA Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

GNCA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Genocea Biosciences Stock vs. The Competition

TypeGenocea BiosciencesMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.64
2.47
Consensus RatingHoldBuyHold
Predicted Upside1,499,900.00% Upside2,503.30% Upside9.44% Upside
News Sentiment RatingNeutral News
Neutral News
Neutral News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/29/2022HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Pantginis
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
4/29/2022Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
4/11/2022Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$8.00 ➝ $3.00+649.98%
4/6/2021SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$5.00 ➝ $6.00+116.61%
2/11/2021Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$7.00 ➝ $6.00+71.43%
(Data available from 2/7/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












GNCA Price Target - Frequently Asked Questions

What is Genocea Biosciences's consensus rating and price target?

According to the issued ratings of 2 analysts in the last year, the consensus rating for Genocea Biosciences stock is Hold based on the current 2 hold ratings for GNCA. The average twelve-month price prediction for Genocea Biosciences is $3.00 with a high price target of $3.00 and a low price target of $3.00. Learn more on GNCA's analyst rating history.

Do Wall Street analysts like Genocea Biosciences more than its competitors?

Analysts like Genocea Biosciences less than other Medical companies. The consensus rating for Genocea Biosciences is Hold while the average consensus rating for medical companies is Buy. Learn more on how GNCA compares to other companies.

Does Genocea Biosciences's stock price have much upside?

According to analysts, Genocea Biosciences's stock has a predicted upside of 650.00% based on their 12-month price targets.


Stock Ratings Reports and Tools

This page (NASDAQ:GNCA) was last updated on 2/7/2023 by MarketBeat.com Staff